Evaluation of contrast agents for delineation of vessel wall boundary by intracoronary ultrasound after coronary angioplasty in human.
We evaluated the potential for improving visualization at intervention sites using contrast-enhanced intracoronary ultrasound (ICUS) and the suitable contrast agents for this procedure in humans. In 37 patients, ICUS (30 MHz) was performed with intracoronary bolus injection (3 mL) of seven different contrast preparations and without the contrast agents (control) after coronary intervention. The contrast agents used were as follows: saline solution, standard iomeprol, standard ioxaglate, sonicated iomeprol, sonicated ioxaglate, 50% Albunex, and 100% Albunex. Homogeneous and complete opacification of the vessel lumen and false lumen was observed with sonicated ioxaglate, 50% and 100% Albunex. Shadowing was not observed at all with sonicated ioxaglate and was uncommon with 50% Albunex, whereas 100% Albunex caused shadowing in all cases. The coronary delineation rate with the other contrast agents was only 60%-70%, and the homogeneity and peak intensity were relatively low. Thus, sonicated ioxaglate and 50% Albunex both achieved good visualization, but the latter is more expensive, more difficult to handle, and takes longer to prepare. Of the agents we studied, sonicated ioxaglate appears to be best suited for contrast-enhanced ICUS. ICUS using suitable contrast agents could only visualize the large dissections and the strategy was changed according to the contrast-enhanced ICUS results in five cases. Thus, suitable contrast agents, e.g., sonicated ioxaglate, should be used during ICUS after intracoronary intervention.
Nishino
M
M
Division of Cardiology, Osaka Rosai Hospital, Sakai-City, Japan. mnishino@orh.go.jp
Tanouchi
J
J
Kawabata
M
M
Tanaka
K
K
Ito
T
T
Kato
J
J
Yamada
Y
Y
Kamada
T
T
D000368:Aged; D000418:Albumins; D015906:Angioplasty, Balloon, Coronary; D003287:Contrast Media; D003327:Coronary Disease / Q000000981:diagnostic imaging* / Q000628:therapy; D003331:Coronary Vessels / Q000000981:diagnostic imaging*; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D007089:Image Enhancement; D007485:Ioxaglic Acid; D008297:Male; D008863:Microspheres; D008875:Middle Aged; D015588:Observer Variation; D018084:Ultrasonography, Interventional / Q000379:methods
D000418:Albumins; C060687:Albunex; D003287:Contrast Media; D007485:Ioxaglic Acid